4.6 Article

Constitutive STAT5 activation regulates Paneth and Paneth-like cells to control Clostridium difficile colitis

期刊

LIFE SCIENCE ALLIANCE
卷 2, 期 2, 页码 -

出版社

LIFE SCIENCE ALLIANCE LLC
DOI: 10.26508/lsa.201900296

关键词

-

类别

资金

  1. Crohn's Colitis Foundation of America Senior Research Award [426234]
  2. NIAID R21 [AI103388]
  3. Cincinnati Children's Hospital Research Foundation Digestive Health Center [P30DK078392]
  4. NIH R01, USA [DK098231]
  5. Austrian Science Fund (FWF), Austria [SFB F4707, SFB-F06105]
  6. [2016RC310011]

向作者/读者索取更多资源

Clostridium difficile impairs Paneth cells, driving intestinal inflammation that exaggerates colitis. Besides secreting bactericidal products to restrain C. difficile, Paneth cells act as guardians that constitute a niche for intestinal epithelial stem cell (IESC) regeneration. However, how IESCs are sustained to specify Paneth-like cells as their niche remains unclear. Cytokine-JAK-STATs are required for IESC regeneration. We investigated how constitutive STAT5 activation (Ca-pYSTAT5) restricts IESC differentiation towards niche cells to restrain C. difficile infection. We generated inducible transgenic mice and organoids to determine the effects of Ca-pYSTAT5-induced IESC lineages on C. difficile colitis. We found that STAT5 absence reduced Paneth cells and predisposed mice to C. difficile ileocolitis. In contrast, Ca-pYSTAT5 enhanced Paneth cell lineage tracing and restricted Lgr5 IESC differentiation towards pYSTAT5(+)Lgr5(-)CD24(+)Lyso(+) or cKit(+) niche cells, which imprinted Lgr5(hi)Ki67(+) IESCs. Mechanistically, pYSTAT5 activated Wnt/beta-catenin signaling to determine Paneth cell fate. In conclusion, Ca-pYSTAT5 gradients control niche differentiation. Lack of pYSTAT5 reduces the niche cells to sustain IESC regeneration and induces C. difficile ileocolitis. STAT5 may be a transcription factor that regulates Paneth cells to maintain niche regeneration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据